NLM Logo

6-((3-cyclobutyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)oxy)-N-methyl-3-pyridinecarboxamide MeSH Supplementary Concept Data 2024


MeSH Supplementary
6-((3-cyclobutyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)oxy)-N-methyl-3-pyridinecarboxamide
Unique ID
C521312
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C521312
Entry Term(s)
GSK 189254
GSK-189254
GSK189254
Registry Number
5T4TX6CO53
Heading Mapped to
*Benzazepines
Niacinamide / *analogs & derivatives
Frequency
26
Note
GSK-189254 is the HCl salt; an H3 receptor antagonist; putative cognitive enhancer; structure in first source
Source
J Pharmacol Exp Ther 2007 Jun;321(3):1032-45
Indexing Information
Receptors, Histamine H3
Date of Entry
2007/07/23
Revision Date
2019/01/07
6-((3-cyclobutyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)oxy)-N-methyl-3-pyridinecarboxamide Preferred
GSK 189254 Narrower
page delivered in 0.005s